PT Ipb Shigeta Animal Pharmaceuticals (Indonesia)

Ipb Shigeta Animal Pharmaceuticals is primarily engaged in pharmaceutical preparations activity. Its headquarters is located in Jawa Barat. The company was founded in 2004. IPB Shigeta Animal Pharmaceuticals was established as a joint venture between Institut Pertanian Bogor (IPB) and Shigeta Animal Pharmaceuticals, a renowned Japanese company. The company focuses on the development and production of veterinary pharmaceuticals, catering to the needs of livestock and companion animals. The primary business line of Ipb Shigeta is the manufacturing of veterinary drugs and vaccines, while its secondary business line includes research and development in animal health solutions. The company has a significant presence in Indonesia, with several branches and distribution centers across the country, ensuring a robust local geographical footprint. IPB Shigeta's main products include antibiotics, antiparasitics, and vaccines, marketed under well-known brand names such as ShigetaVet and IPBPharm. The company is committed to enhancing animal health and productivity through innovative and effective pharmaceutical solutions. Globally, Ipb Shigeta Animal Pharmaceuticals has expanded its operations to several Southeast Asian countries, establishing a strong presence in the region. The company collaborates with various international partners and is a member of several industry associations, which helps it stay at the forefront of veterinary pharmaceutical advancements. IPB Shigeta is dedicated to sustainable practices and aims to contribute to the improvement of animal health and welfare. The company's mission is to provide high-quality, safe, and effective pharmaceutical products that support the agricultural and veterinary sectors, ultimately enhancing food security and public health.